Research Project
Grant-in-Aid for Research Activity Start-up
Altered regulation of ER stress response has been implicated in a variety of human diseases. Excessive ER function contributes to malignant phenotypes, such as chemoresistance and metastasis. Here we identified that the tumor suppressor p53 regulates ER function in response to stresses. We found that loss of p53 function activates the IRE1α/XBP1 pathway to enhance protein folding and secretion through upregulation of IRE1α and subsequent activation of its target XBP1. Moreover, IRE1α inhibitor suppressed protein secretion, induced cell death in p53-deficient cells, and strongly suppressed the formation of tumors by p53-deficient human tumor cells in vivo compared with those that expressed wild-type p53. Therefore, our data imply that the IRE1α/XBP1 pathway serves as a target for therapy of chemoresistant tumors that express mutant p53.
All 2015 2014 Other
All Int'l Joint Research (1 results) Journal Article (4 results) (of which Int'l Joint Research: 3 results, Peer Reviewed: 2 results, Open Access: 3 results, Acknowledgement Compliant: 1 results) Presentation (2 results) Remarks (2 results)
Oncotarget
Volume: 24 Issue: 24 Pages: 19990-20001
10.18632/oncotarget.4598
Chemstry & Biology
Volume: 22 Issue: 9 Pages: 1206-1216
10.1016/j.chembiol.2015.07.016
Aging
Volume: 7 Pages: 901-902
Volume: 7 Pages: 895-896
http://www.cc.kochi-u.ac.jp/~t-namba/
http://www.kochi-u.ac.jp/information/2016010600039/